Second from the left: Ms. Wang Huijuan
First from the right: Deputy Secretary-General Feng Qiang

  On February 9, 2026, Ms. Wang Huijuan, Consultant of the British SIGMA Pharmaceutical Company, visited Eastwud Pharmaceutical for a specialized inspection and research. Founded in 1982, SIGMA Pharmaceutical is a large-scale pharmaceutical wholesaler and distributor headquartered in London, serving over 3,000 pharmacies, 1,000 hospitals, and 600 dispensing clinics. Prior to this visit, the two parties had officially signed a confidentiality agreement in October 2025, initiating in-depth discussions on potential areas of collaboration. During the inspection, Ms. Wang Huijuan, representing SIGMA Pharmaceutical, conducted a comprehensive and meticulous on-site assessment of Eastwud Pharmaceutical's production capacity, process control, and management systems. She commended the company's advanced hardware facilities and standardized, efficient operational management, laying a solid foundation for advancing concrete product cooperation between the two parties.

 
  This series of inspection and research activities has not only established a strong bridge for multi-party communication and collaboration but has also injected robust momentum into the high-quality development of Eastwud Pharmaceutical. It will help the company consolidate its competitive advantages in the industry and achieve steady progress.